Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Lundbeck discloses new PDE10A inhibitors

June 15, 2012

AstraZeneca and Dainippon Sumitomo Pharma present new TLR7 agonists

June 15, 2012

Instituto Biomar reports new agents from a marine microorganism

June 14, 2012

New antisense oligonucleotides designed at Japanese university

June 14, 2012

U.S. researchers disclose novel metalloenzyme inhibitors

June 14, 2012

Celgene patents novel inhibitors of mutant EGFR

June 14, 2012

New agents for pulmonary hypertension presented by Ironwood Pharmaceuticals

June 14, 2012

Novel anticancer TLR7 agonists disclosed

June 14, 2012

Jenrin Discovery designs novel compounds targeting the cannabinoid CB1 receptor

June 14, 2012

Novel agents for migraine prepared at Merck & Co.

June 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...